Catalyst
Slingshot members are tracking this event:
PDUFA Date of April 29th for Ariad's (ARIA) Brigatinib in ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 28, 2017
Occurred Source:
http://investor.ariad.com/phoenix.zhtml?c=118422&p=irol-newsArticle&ID=2267122
Related Projects
Related Keywords
Pdufa, Brigatinib, Alk-positive, Non-small Cell Lung Cancer, Nsclc, Fda, New Drug Application, Nda